ModuLight.bio · raw details

Optogenetics-based Platform for Neuro-excitatory Conditions · Ramat Gan · Founded 2022

active Seed ← back to profile
Website ↗

Highlights

1 patentProfile claimed by owner

About

Optogenetics-based Platform for Neuro-excitatory Conditions

Modulight is developing an optogenetics-based platform for treating neuronal overactivation disorders, regardless of their specific underlying cause.

The company aims to revolutionize the treatment of severe neurological conditions for millions of people worldwide.

Identity

NameModuLight.bio
Slugmodulight-bio
Type / kindstartup
Source _idgKPgu3Q1BWoSMnjyOPxZx4Sf4teoCe1Iuti6pyCsqkc4u0dzfR8VMM

Status

Statusactive
Last update2026-05-17

Location

HQ country codeIL
HQ cityRamat Gan
HQ addressBezalel St 1, Ramat Gan, Israel

Web & social

Websitehttps://www.modulight.bio/

Classifications

Primary sector Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
BiologicalsCells
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business models
B2B
Tags
neuro-stimulationpharmaceuticalsneurology

Funding

Total raised$6.7M
Current stageSeed

Raw source document

Show full JSON (0 KB) 
{
  "0": "s",
  "1": "l",
  "2": "i",
  "3": "m",
  "4": "p",
  "5": "a",
  "6": "g",
  "7": "e",
  "8": "s",
  "9": "_",
  "10": "i",
  "11": "m",
  "12": "p",
  "13": "o",
  "14": "r",
  "15": "t"
}